Abstract
Electrocardiographic evidence of left ventricular hypertrophy (ECG-LVH) has a grave prognostic significance in hypertensive patients. The purpose of our study was to assess whether ECG-LVH is more strongly associated with home-measured blood pressure (BP) than with clinic BP, and whether the correlation between home BP and ECG-LVH increases with the number of home measurements performed. We studied a representative sample of the general adult population (1989 subjects 45–74 years of age) in Finland. Subjects included in the study underwent a clinical interview, electrocardiography and measurement of clinic BP (mean of two clinic measurements) and home BP (mean of 14 duplicate home measurements performed during 1 week). Home BP correlated significantly better than clinic BP with the Sokolow–Lyon voltage (home/clinic systolic: r=0.23/0.22, P=0.60; diastolic: r=0.17/0.12, P=0.009), Cornell voltage (systolic: r=0.30/0.25, P=0.004; diastolic: r=0.21/0.12, P<0.001) and Cornell product (systolic: r=0.30/0.24, P=0.001; diastolic r=0.22/0.14, P<0.001) criteria of ECG-LVH. The correlation between home BP and ECG-LVH increased slightly with the number of home measurements, but even the mean of the initial two home BP measurements correlated equally well (systolic BP), or better (diastolic BP) with ECG-LVH than did clinic BP. In conclusion, home BP measurement allows us to obtain a large number of measurements that have a strong association with ECG-LVH. Our data support the application of home BP measurement in clinical practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens 2002; 15: 101–104.
Ohkubo T, Imai Y, Tsuji I, Nagai K, Kato J, Kikuchi N et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971–975.
Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B et al. Cardiovascular prognosis of ‘masked hypertension’ detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342–1349.
Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population. Follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777–1783.
Kannel WB . Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75: 4–11.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK . The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557–1562.
Mule G, Caimi G, Cottone S, Nardi E, Andronico G, Piazza G et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk 2002; 9: 123–129.
Tsunoda S, Kawano Y, Horio T, Okuda N, Takishita S . Relationship between home blood pressure and longitudinal changes in target organ damage in treated hypertensive patients. Hypertens Res 2002; 25: 167–173.
Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004; 292: 2343–2349.
Sokolow M, Werdegar D, Kain HK, Hinman AT . Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation 1966; 34: 279–298.
Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G . Relationship of 24-h blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5: 93–98.
Niiranen TJ, Jula AM, Kantola IM, Reunanen A . Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens 2006; 24: 463–470.
Aromaa A, Koskinen S . Health and Functional Capacity in Finland. Baseline Results of the Health 2000 Health Examination Survey. National Public Health Institute: Helsinki, 2004. Available at: http://www.ktl.fi/terveys2000/julkaisut/baseline.pdf.
Rose G, Blackburn H, Gillum R, Prineas R . Cardiovascular Survey Methods, 2nd edn. World Health Organization: Geneva, 1982.
Bortolotto LA, Henry O, Hanon O, Sikias P, Mourad JJ, Girerd X . Validation of two devices for self-measurement of blood pressure by elderly patients according to the revised British Hypertension Society protocol: the Omron HEM-722C and HEM-735C. Blood Press Monit 1999; 4: 21–25.
O’Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821–848.
Sokolow M, Lyon T . The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949; 37: 161–186.
Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Dahlof B . Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension 2000; 36: 766–773.
Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Guerrieri M, Zampi I et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994; 74: 714–719.
Molloy TJ, Okin PM, Devereux RB, Kligfield P . Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage-duration product. J Am Coll Cardiol 1992; 20: 1180–1186.
Jöreskog KG, Sörbom D . LISREL 8: User's Reference Guide. Scientific Software International: Chicago, 1996.
Marcus R, Krause L, Weder AB, Dominguez-Meja A, Schork NJ, Julius S . Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928–936.
Jula AM, Karanko HM . Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension. Circulation 1994; 89: 1023–1031.
Kupari M, Koskinen P, Virolainen J . Correlates of left ventricular mass in a population sample aged 36 to 37 years. Focus on lifestyle and salt intake. Circulation 1994; 89: 1041–1050.
Antikainen R, Grodzicki T, Palmer AJ, Beevers DG, Coles EC, Webster J et al. The determinants of left ventricular hypertrophy defined by Sokolow–Lyon criteria in untreated hypertensive patients. J Hum Hypertens 2003; 17: 159–164.
Okin PM, Jern S, Devereux RB, Kjeldsen SE, Dahlof B . Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension 2000; 35: 13–18.
O’Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23: 697–701.
Pickering T . Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1996; 9: 1–11.
Ohkubo T, Asayama K, Kikuya M, Metoki H, Hoshi H, Hashimoto J et al. How many times should blood pressure be measured at home for better prediction of stroke risk? Ten-year follow-up results from the Ohasama study. J Hypertens 2004; 22: 1099–1104.
Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens 2002; 15: 101–104.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Niiranen, T., Jula, A., Kantola, I. et al. Home-measured blood pressure is more strongly associated with electrocardiographic left ventricular hypertrophy than is clinic blood pressure: the Finn-HOME study. J Hum Hypertens 21, 788–794 (2007). https://doi.org/10.1038/sj.jhh.1002192
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1002192
Keywords
This article is cited by
-
Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study
Hypertension Research (2023)
-
Factors affecting variability in home blood pressure in patients with type 2 diabetes: post hoc analysis of a cross-sectional multicenter study
Journal of Human Hypertension (2014)
-
Home Blood Pressure Monitoring in the Diagnosis and Treatment of Hypertension: A Systematic Review
American Journal of Hypertension (2011)
-
Electrocardiographic abnormalities and home blood pressure in treated elderly hypertensive patients: Japan home versus office blood pressure measurement evaluation in the elderly (J-HOME-Elderly) study
Hypertension Research (2010)
-
Prediction of albuminuria by different blood pressure measurement methods in type 1 diabetes: a pilot study
Hypertension Research (2009)